Anatomy of the PBRER

ICH E2C(R2)’s full PBRER structure runs through roughly seventeen numbered sections and sub-sections, and rather than listing every one, this lesson groups them into the major structural blocks a medical writer actually works through, in the order they’re worked through — because the report is built to be read, and written, as a logical progression, not a set of independent chapters.

It opens with introduction and worldwide marketing status content — the reporting interval being covered, the product’s international birth date, and where it’s currently authorised, marketed, or has been withdrawn — and moves quickly into any actions taken for safety reasons during the interval, whether regulatory or company-initiated. From there it establishes patient exposure and use, both cumulative and for the specific interval, which is the denominator every rate-based interpretation in the rest of the report depends on, and which Lesson 8.5 covers in its own depth.

The data summary tabulations that follow are structured presentations of serious and non-serious case counts, organised by MedDRA System Organ Class — and this is exactly the point in the report where Module 4’s emphasis on consistent, specific coding pays off directly or exacts its cost: a coding practice that scatters genuinely related events across loosely-connected LLTs makes these tabulations less informative, understating patterns a careful reviewer might otherwise catch. From there, summaries of significant findings pull together clinical trial, literature, and other-source safety information from the interval, and signal and risk evaluation reports on every signal from Module 7 that was validated or under assessment during the period, including the outcome of that assessment.

All of it builds toward the benefit-risk analysis — the section this module dedicates Lesson 8.7 to in full, and the section every earlier part of the report exists to support. A PBRER whose data summaries are sloppy, whose signal evaluation section is incomplete, or whose exposure estimates are unreliable produces a benefit-risk analysis built on a weak foundation, regardless of how well-written that final section is in isolation — which is exactly why this lesson presents the structure as a sequence that builds, rather than a checklist of independent parts.